Page last updated: 2024-08-26

ly 117018 and afimoxifene

ly 117018 has been researched along with afimoxifene in 19 studies

Research

Studies (19)

TimeframeStudies, this research(%)All Research%
pre-199011 (57.89)18.7374
1990's4 (21.05)18.2507
2000's4 (21.05)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ballejo, G; Gong, Y; Murphy, LC; Murphy, LJ1
Koga, M; Sutherland, RL2
Dickson, RB; Katz, D; Lippman, ME; Shima, TB; Thompson, EW; Wakeling, AE1
Katzenellenbogen, BS; Toney, TW1
Crastes de Paulet, A; Cypriani, B; Descomps, B; Tabacik, C1
Campen, CA; Gorski, J; Jordan, VC1
Bronzert, DA; Greene, GL; Lippman, ME1
Jordan, VC1
Green, LR; Newboult, E; Valcaccia, B; Wakeling, AE1
Gosden, B; Jordan, VC2
Jordan, VC; Mueller, GC; Olsen, MR; Tate, AC; Van Oosbree, TR1
Borras, M; Bouhoute, A; Jin, L; Leclercq, G; Legros, N1
Berthois, Y; Crastes de Paulet, A; Dussert, C; Martin, PM; Pons, M1
Balaguer, P; Bonnet, S; Cavaillès, V; Duong, V; Escande, A; Margueron, R; Vignon, F1
Body, JJ; Journé, F; Laurent, G; Leclercq, G; Nonclercq, D1
Benjamins, JA; Deighton-Collins, S; Guzmán, CB; Kleerekoper, M; Martinez, A; Skafar, DF; Zhao, C1
Clarke, R; Dai, P; Lou, MA; Lu, JF; Nazarov, V; Wong, LJ1

Reviews

1 review(s) available for ly 117018 and afimoxifene

ArticleYear
Laboratory studies to develop general principles for the adjuvant treatment of breast cancer with antiestrogens: problems and potential for future clinical applications.
    Breast cancer research and treatment, 1983, Volume: 3 Suppl

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Disease Models, Animal; Dose-Response Relationship, Drug; Estrogen Antagonists; Female; Half-Life; Humans; Mammary Neoplasms, Experimental; Models, Biological; Piperidines; Pyrrolidines; Raloxifene Hydrochloride; Rats; Rats, Inbred Strains; Receptors, Estrogen; Tamoxifen; Thiophenes

1983

Other Studies

18 other study(ies) available for ly 117018 and afimoxifene

ArticleYear
Differential effects of estrogen and antiestrogen on transforming growth factor gene expression in endometrial adenocarcinoma cells.
    Cancer research, 1992, Apr-01, Volume: 52, Issue:7

    Topics: Adenocarcinoma; Analysis of Variance; Cell Division; Cell Line; Dose-Response Relationship, Drug; Endometrial Neoplasms; ErbB Receptors; Estradiol; Estrogen Antagonists; Female; Gene Expression; Humans; Kinetics; Polyunsaturated Alkamides; Pyrrolidines; RNA, Messenger; Tamoxifen; Thiophenes; Transforming Growth Factor alpha; Tumor Cells, Cultured

1992
Retinoic acid acts synergistically with 1,25-dihydroxyvitamin D3 or antioestrogen to inhibit T-47D human breast cancer cell proliferation.
    The Journal of steroid biochemistry and molecular biology, 1991, Volume: 39, Issue:4A

    Topics: Breast Neoplasms; Calcitriol; Cell Division; Cell Line; Clomiphene; Drug Synergism; Estradiol; Estrogen Antagonists; Female; Humans; Kinetics; Pyrrolidines; Receptors, Calcitriol; Receptors, Estradiol; Receptors, Steroid; Tamoxifen; Thiophenes; Tretinoin

1991
ICI 164,384, a pure antagonist of estrogen-stimulated MCF-7 cell proliferation and invasiveness.
    Cancer research, 1989, Dec-15, Volume: 49, Issue:24 Pt 1

    Topics: Basement Membrane; Binding, Competitive; Breast Neoplasms; Cell Cycle; Estradiol; Estrogen Antagonists; Humans; Neoplasm Invasiveness; Polyunsaturated Alkamides; Pyrrolidines; Receptors, Estrogen; Stimulation, Chemical; Tamoxifen; Thiophenes; Tumor Cells, Cultured

1989
An evaluation of the interactions of antiestrogens with pituitary and striatal dopamine receptors.
    Journal of receptor research, 1987, Volume: 7, Issue:5

    Topics: Animals; Binding, Competitive; Cell Membrane; Corpus Striatum; Diethylamines; Estrogen Antagonists; Female; Nitromifene; Pituitary Gland, Anterior; Pyrrolidines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Spiperone; Tamoxifen; Thiophenes

1987
Role of estrogen receptors and antiestrogen binding sites in an early effect of antiestrogens, the inhibition of cholesterol biosynthesis.
    Journal of steroid biochemistry, 1988, Volume: 31, Issue:5

    Topics: Animals; Binding Sites; Cell Division; Cell Line; Cholesterol; Humans; Molecular Weight; Pyrrolidines; Rats; Receptors, Drug; Receptors, Estrogen; Tamoxifen; Thiophenes; Tumor Cells, Cultured

1988
Epidermal growth factor partially reverses the inhibitory effects of antiestrogens on T 47D human breast cancer cell growth.
    Biochemical and biophysical research communications, 1987, Jul-31, Volume: 146, Issue:2

    Topics: Breast Neoplasms; Cell Division; Cell Line; Clomiphene; Epidermal Growth Factor; Estrogen Antagonists; Humans; Pyrrolidines; Tamoxifen; Thiophenes

1987
Opposing biological actions of antiestrogens in vitro and in vivo: induction of progesterone receptor in the rat and mouse uterus.
    Endocrinology, 1985, Volume: 116, Issue:6

    Topics: Animals; Cells, Cultured; Estradiol; Estrogen Antagonists; Female; In Vitro Techniques; Mice; Mice, Inbred ICR; Pyrrolidines; Rats; Receptors, Progesterone; Species Specificity; Stereoisomerism; Structure-Activity Relationship; Tamoxifen; Thiophenes; Uterus

1985
Selection and characterization of a breast cancer cell line resistant to the antiestrogen LY 117018.
    Endocrinology, 1985, Volume: 117, Issue:4

    Topics: Binding, Competitive; Breast Neoplasms; Cell Division; Cell Line; Drug Resistance; Estradiol; Female; Humans; Molecular Weight; Phenotype; Pyrrolidines; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Thiophenes

1985
Non-steroidal antioestrogens--receptor binding and biological response in rat uterus, rat mammary carcinoma and human breast cancer cells.
    Journal of steroid biochemistry, 1984, Volume: 20, Issue:1

    Topics: Animals; Breast Neoplasms; Cell Line; Estrogen Antagonists; Female; Humans; Mammary Neoplasms, Experimental; Piperidines; Pyrrolidines; Raloxifene Hydrochloride; Rats; Receptors, Estrogen; Tamoxifen; Thiophenes; Uterus

1984
Differential antiestrogen action in the immature rat uterus: a comparison of hydroxylated antiestrogens with high affinity for the estrogen receptor.
    Journal of steroid biochemistry, 1983, Volume: 19, Issue:3

    Topics: Animals; Binding, Competitive; Estrogen Antagonists; Female; Kinetics; Organ Size; Promegestone; Pyrrolidines; Rats; Rats, Inbred Strains; Receptors, Estrogen; Sexual Maturation; Tamoxifen; Thiophenes; Uterus

1983
An immobilized antiestrogen binds a specific uterine protein in addition to estrogen receptor proteins.
    Molecular and cellular endocrinology, 1984, Volume: 35, Issue:2-3

    Topics: Agar; Animals; Carrier Proteins; Cytosol; Estrogen Antagonists; Female; Molecular Weight; Pyrrolidines; Rats; Receptors, Estrogen; Tamoxifen; Thiophenes; Uterus

1984
Inhibition of the uterotropic activity of estrogens and antiestrogens by the short acting antiestrogen LY117018.
    Endocrinology, 1983, Volume: 113, Issue:2

    Topics: Animals; Castration; Estradiol; Estrogen Antagonists; Female; Mice; Organ Size; Pyrrolidines; Rats; Rats, Inbred Strains; Structure-Activity Relationship; Tamoxifen; Thiophenes; Uterus

1983
Evaluation of estrogen receptor, antiestrogen binding sites and calmodulin for antiestrogen resistance of two clones derived from the MCF-7 breast cancer cell line.
    Biochemical pharmacology, 1994, Nov-29, Volume: 48, Issue:11

    Topics: Binding Sites; Calmodulin; Cell Division; Clone Cells; Drug Resistance; Estrogen Antagonists; Humans; Imidazoles; Pyrrolidines; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Thiophenes; Tumor Cells, Cultured

1994
Agonist-antagonist activity of anti-estrogens in the human breast cancer cell line MCF-7: an hypothesis for the interaction with a site distinct from the estrogen binding site.
    Molecular and cellular endocrinology, 1994, Volume: 99, Issue:2

    Topics: Binding, Competitive; Breast Neoplasms; Cell Division; Cell Fractionation; Centrifugation, Density Gradient; Cytosol; Estradiol; Estrogen Antagonists; Humans; Pyrrolidines; Receptors, Estrogen; Tamoxifen; Thiophenes; Tumor Cells, Cultured

1994
Histone deacetylase inhibition and estrogen receptor alpha levels modulate the transcriptional activity of partial antiestrogens.
    Journal of molecular endocrinology, 2004, Volume: 32, Issue:2

    Topics: Breast Neoplasms; Enzyme Inhibitors; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogen Receptor Modulators; Female; Fulvestrant; Genes, Reporter; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Pyrrolidines; Raloxifene Hydrochloride; Response Elements; Tamoxifen; Thiophenes; Transcription, Genetic; Tumor Cells, Cultured

2004
Ligand-independent and agonist-mediated degradation of estrogen receptor-alpha in breast carcinoma cells: evidence for distinct degradative pathways.
    Molecular and cellular endocrinology, 2004, Nov-30, Volume: 227, Issue:1-2

    Topics: Breast Neoplasms; Cycloheximide; Enzyme Inhibitors; Estrogen Antagonists; Estrogen Receptor alpha; Female; Fluorescent Antibody Technique; Gene Expression Regulation, Neoplastic; HSP90 Heat-Shock Proteins; Humans; Immunoenzyme Techniques; Lactones; Leupeptins; Ligands; Macrolides; Molecular Chaperones; Proteasome Inhibitors; Protein Synthesis Inhibitors; Protein-Tyrosine Kinases; Pyrrolidines; Signal Transduction; Tamoxifen; Thiophenes; Tumor Cells, Cultured

2004
Activity of estradiol and selective estrogen receptor modulators in the mouse N20.1 oligodendrocyte/astrocytes cell line.
    Neuro endocrinology letters, 2005, Volume: 26, Issue:5

    Topics: Animals; Astrocytes; Blotting, Western; Cell Line; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Gene Expression Regulation; Ligands; Luciferases; Mice; Neuroglia; Oligodendroglia; Plasmids; Pyrrolidines; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen; Thiophenes; Transfection

2005
AIB1 gene amplification and the instability of polyQ encoding sequence in breast cancer cell lines.
    BMC cancer, 2006, May-02, Volume: 6

    Topics: Acetyltransferases; Alleles; Breast Neoplasms; Cell Line, Tumor; Cloning, Molecular; Drug Resistance, Neoplasm; Estradiol; Fulvestrant; Histone Acetyltransferases; Humans; Nuclear Receptor Coactivator 3; Oncogene Proteins; Peptides; Polymerase Chain Reaction; Pyrrolidines; Raloxifene Hydrochloride; Reverse Transcriptase Polymerase Chain Reaction; Selective Estrogen Receptor Modulators; Sequence Analysis, DNA; Tamoxifen; Thiophenes; Trans-Activators

2006